TickerFacts.

TG Therapeutics, Inc. (TGTX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

161.41M
Year ended 2025-12-31
+6.0%
3-year compound annual growth
+7.0%
5-year compound annual growth
2020-12-31: 115.33M2021-12-31: 132.22M2022-12-31: 135.41M2023-12-31: 148.51M2024-12-31: 160.34M2025-12-31: 161.41M161.41M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31161.41M+0.7%2026-02-27, From 2025-01-01
2024-12-31160.34M+8.0%2026-02-27, From 2024-01-01
2023-12-31148.51M+9.7%2026-02-27, From 2023-01-01
2022-12-31135.41M+2.4%2025-03-03, From 2022-01-01
2021-12-31132.22M+14.6%2024-02-29, From 2021-01-01
2020-12-31115.33Mn/a2023-03-01, From 2020-01-01